Suk-Young Yoo

Suk-Young Yoo

UNVERIFIED PROFILE

Are you Suk-Young Yoo?   Register this Author

Register author
Suk-Young Yoo

Suk-Young Yoo

Publications by authors named "Suk-Young Yoo"

Are you Suk-Young Yoo?   Register this Author

23Publications

799Reads

50Profile Views

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance.

Mol Cancer Res 2018 08 18;16(8):1263-1274. Epub 2018 Apr 18.

Department of Pediatrics, Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-17-0730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496939PMC
August 2018

Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients.

Proteomics 2018 04 2;18(8):e1700379. Epub 2018 Apr 2.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pmic.201700379
Publisher Site
http://dx.doi.org/10.1002/pmic.201700379DOI Listing
April 2018

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.

PLoS One 2017 15;12(12):e0189965. Epub 2017 Dec 15.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189965PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731750PMC
January 2018

Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice.

Clin Cancer Res 2017 Sep 22;23(18):5537-5546. Epub 2017 May 22.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873583PMC
September 2017

Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.

Leuk Lymphoma 2017 05 13;58(5):1207-1218. Epub 2016 Oct 13.

c Division of Molecular Hematology, Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2016.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2016.1235272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994918PMC
May 2017

Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.

J Natl Cancer Inst 2014 Mar 22;106(3):dju004. Epub 2014 Feb 22.

Affiliations of authors: Department of Translational Molecular Pathology (HK, JF, TM, MMG, C-WC, ZC, GM, IIW), Department of Thoracic/Head and Neck Medical Oncology (MK, WKH, IIW), Department of Pathology (NK, CM), Department of Bioinformatics (S-YY, LS, JW, KRC), University of Texas MD Anderson Cancer Center, Houston, TX; Section of Computational Medicine, Department of Medicine, Boston University, Boston, MA (ACG, AS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982778PMC
March 2014

KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.

Cancer Res 2013 Sep 3;73(17):5532-43. Epub 2013 Jul 3.

Departments of Thoracic and Cardiovascular Surgery, Bioinformatics and Computational Biology, and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868367PMC
September 2013